Hepatitis C treatment.

Abstract

Guidance for hepatitis C treatment in adults is changing frequently with the advent of new therapies and maturing studies. A static version of this guidance, such as website material, booklets, slides, and other materials, may be outdated by the time you read this. UHA will base coverage determination for treatment of Hepatitis C on the latest available scientifically valid recommendation. At this time, UHA recognizes the clinical criteria for treatment of the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) and limits coverage to those patients who will realize the highest benefit of pharmacologic therapy. These recommendations can be found at: